The evolution of CGRP-related migraine research has progressively refined research clusters, advancing from elucidating CGRP mechanisms to assessing the efficacy and safety of CGRP receptor antagonists and monoclonal antibodies. The gene discussed is CALCA; the disease is migraine disorder.